- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
EPA Will Accelerate Review of Environmental Contaminants and Increase Transparency of Scientific Information
The Integrated Risk Information System is an Environmental Protection Agency database of information on the human health effects of exposure to environmental contaminants. Before getting cataloged in the system, a contaminant must go through the IRIS process, a set of steps to evaluate the substance that include EPA review, interagency science consultation, and external peer review. Critics of the process complain that it can take decades to assess the danger level of substances that may continue to jeopardize public health. However, EPA announced significant updates to the procedure last month that will streamline the review process to an average of 23 months.
This morning, the Senate Environment and Public Works Committee and Subcommittee on Oversight held a joint hearing on “Scientific Integrity and Transparency Reforms at the Environmental Protection Agency,” which included discussion of the new procedures. Lisa Jackson, administrator of the EPA, testified on how the new IRIS process will help fulfill President Obama’s memorandum on scientific integrity by increasing transparency in science-based regulation.
EPA will now manage the entire IRIS review process, rather than the Office of Management and Budget, Jackson said. Dr. Francesca Grifo, Senior Scientist and Director of the Scientific Integrity Program at the Union of Concerned Scientists, discussed the importance of this change in control in a Science Progress podcast last month. The OMB previously had the power to change scientific advice, Grifo said, and described the problematic regulatory process under the Bush administration. “What we saw in the past was, rather than be courageous and come out and talk about which parts were policy and which parts were science, we saw changes in the science to cover up an often unpopular policy decision,” she said. Grifo explained in that interview that administration policy could break with the scientific advice, but the reasoning had to be clear, rather than resorting to an obfuscation of the data. “The key here is for all of us to see the scientific basis,” she said.
The new IRIS process requires that all written scientific comments on IRIS drafts provided by federal agencies be made public. Furthermore, most contaminant evaluations will be available on IRIS within two years of the review start date, Jackson said. The condensed process not only presents health-related information to the public more quickly, but also eliminates steps agencies could potentially use to inhibit the process, explained John B. Stephenson, director of natural resources & environment at the U.S. Government Accountability Office. Under the old rules, agencies could declare a need for additional research to suspend the IRIS process and prevent or delay a substance from being added to the database. This gave agencies time to present studies that conflicted with the original “best available science,” Stephenson said.
Image: AP
Comments on this article


